Founded in 1975, Laminar Medica is based in Tring, Hertfordshire, United Kingdom. The company provides temperature-controlled packaging for many of the world’s leading pharmaceutical companies to help maintain the quality and potency of medical products that could potentially be affected by temperature variations during transit. Organizations throughout the healthcare sector, including pharmaceutical manufacturers, laboratories, hospitals, veterinary practices and blood banks as well as specialist courier companies and cargo freight forwarders, rely on Laminar Medica products. The company has facilities in the United Kingdom, the Czech Republic, the United States, Canada, India, Singapore and China. Laminar Medica is part of the CliniMed Group, which includes seven companies that provide specialty products and services for the healthcare market.
It is difficult to maintain commercial relationships with major global customers over the long term without continuing to represent great value, in the face of continual product/service innovation from the competition.
Laminar Medica wanted to improve its insight into the competition. With the healthcare sector producing increasing numbers of novel, high-value drugs that require temperature control to remain effective, competition for packaging solutions within its niche has grown fierce. The growth of this market has attracted major players from other segments of the packaging industry, which are able to exploit their existing knowledge and global manufacturing capabilities. Additional competition comes in the form of alternatives to packaging, such as refrigerated transport providers and air cargo operators.
With so much competition entering the marketplace, Laminar Medica sought to continue to foster its relationships with existing customers. “It is difficult to maintain commercial relationships with major global customers over the long term without continuing to represent great value, in the face of continual product/service innovation from the competition,” says Mark Cooper, market intelligence coordinator, Laminar Medica. Plus, operating on a global basis entails many challenges. To remain competitive, Laminar Medica must keep track of which solutions are available to customers in each global region, along with differences in regional market requirements, like outdoor temperatures, transport and warehouse infrastructures, regulatory practices and levels of access to specialist healthcare.
Laminar Medica needed to rethink its strategies and create an e-business approach for continued business growth when developing its next generation of products. To accomplish these goals, the company needed to benchmark competitors’ performance and analyze insight from various market intelligence sources.
We chose UNICOM because of its ability to provide a complete solution with standard components that met current and longer-term strategic needs of the business.
Laminar Medica reviewed solutions from many vendors before choosing UNICOM Focal Point software. “We chose UNICOM because of its ability to provide a complete solution with standard components that met current and longer-term strategic needs of the business,” says Cooper. In addition, Cooper remarks that the UNICOM solution was the most intuitive and most customizable. To help Laminar Medica transform its operational and strategic goals into reality, a software services team provided hands-on training and remote mentoring during the early stages of the software deployment.
Using Focal Point software, Laminar Medica established a centralized, companywide, role-based resource for competitive and marketplace intelligence, including industry segmentation, news items, industry issues, trade bodies, competitor and product profiles, customer information and prospects. The Focal Point application enables Laminar Medica to consolidate various sources and formats of information into a single analysis environment, making it easier to compare and cross-reference data. Laminar Medica can then create analytical scenarios, including a single competitor or multiple competitors, and easily perform product benchmarking.
Using the solution, Laminar has already reduced its new product development time and associated costs by over 25 percent and simultaneously increased the actual value generated for its customers and internally.
The solution transformed the way Laminar Medica makes product and portfolio decisions. “Previously, it has been difficult for the organization to consider all areas of business/market intelligence that influence long-term strategic thinking and customer requirements. Areas of intelligence, such as customer market sectors, end user feedback, analysis of competitors and product lines, internal opinions, trade bodies, trade press and other sources of industry news, would typically be considered on an individual basis,” says Cooper.
Now, the company uses the application to simulate product investment decision impact, track feature and functionality requirement movement in the marketplace, benchmark competitor performance and generate proactive information that supports tactical bidding scenarios. Using this insight, Laminar Medica retired many products based on projected sales and established clear priorities for future product development projects.
“Using the solution, Laminar has already reduced its new product development time and associated costs by over 25 percent and simultaneously increased the actual value generated for its customers and internally,” says Cooper. The company anticipates that it will achieve a complete ROI in less than 12 months from the time the new products go to market. Laminar Medica’s new products have gained the attention of some large potential customers that were previously impenetrable, before the new products were even ready for commercial release. Finally, the company has been short-listed for or has won 10 percent more competitive tenders, compared to the equivalent period before the launch of the Focal Point solution.
In an increasingly competitive marketplace, Laminar Medica wantedto improve its insight into the competition to support future business growth.
The company used UNICOM Focal Point software to create a companywide resource for competitive intelligence that supports market-driven product development and more-informed portfolio decisions.
Laminar Medica reduced new product development time and associated costs by more than 25 percent. The company anticipates that it will achieve a complete ROI in less than 12 months.